EIKN Earnings Date: Nov 12, 2026 (Estimated) — Eikon Therapeutics, Inc. Common Stock
NASDAQ
Updated
When is EIKN's next earnings date?
Eikon Therapeutics, Inc. Common Stock (EIKN) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 5:27 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$1.74.
How did EIKN do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), Eikon Therapeutics, Inc. Common Stock posted EPS of -$1.63 versus the -$1.58 estimate, a miss of 9.4%. Revenue was $0. The stock's 1-day post-earnings move was +7.0%.
How much does EIKN stock move after earnings?
EIKN beat EPS estimates in 2 of its last 3 reported quarters. Over the last 3 reports the stock moved an average of 8.1% (up or down) in the day after earnings.
About Eikon Therapeutics, Inc. Common Stock
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -1.58 | -1.63 | -9.40% | $0 | ❌ Miss | +6.97% | +4.07% | -9.39% |
| 2026-05-11 | Q1 2026 | -4.07 | -2.46 | +39.56% | $0 | ✅ Beat | +15.88% | +18.09% | -15.98% |
| 2026-03-30 | Q4 2025 | -1.58 | -1.48 | +6.33% | $0 | ✅ Beat | -1.33% | -3.77% | -12.74% |
Showing last 3 quarters.